Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 4.019
Filter
1.
J Integr Neurosci ; 21(1): 11, 2022 Jan 28.
Article in English | MEDLINE | ID: mdl-35164447

ABSTRACT

According to the recent findings, autophagy modulation is being a potential therapeutic target in the management of ischemic stroke in a pre-clinical setting. However, the pros and cons of autophagic response strongly depend on the activation time of autophagy after injury. In this systematic review, we aimed to explore the impacts of pharmacological modulation of autophagy on infarct size in experimental ischemic stroke models. Based on our preliminary search, 3551 publications were identified. Of twenty-nine publications that met the inclusion criteria, twenty studies reported infarct volume reduction by percentage (%) with no evidence of any publication bias while nine studies reported by mm3, which had publication bias (39.25 units, standardized mean differences (SMD) = 41.92, 95% confidence interval (CI): 30.33 to 53.51). Based on a meta-analysis, the point estimate (pooled mean difference) for improvement of infarct volume during autophagy modulation according to the mm3 and percentage were 35.64 (mean differences (MD) = 35.64, 95% CI: 26.43 to 44.85, z-value = 7.58, p-value < 0.001) and 14.38 (MD = 14.38, 95% CI = 10.50 to 18.26, z-value = 7.26, p < 0.001) units, respectively. Despite the undeniable role of autophagy in ischemic stroke, the dichotomous effects of autophagy regarding infarct volume reduction should be taken into account. Based on our findings, the studies included in this meta-analysis mostly reported a negative relation between autophagy induction and stroke volume development due to over-activity of autophagy upon the severe ischemic stroke; therefore, further pre-clinical studies are also recommended to establish adjusted autophagy with considering a time-dependent effect as a promising therapeutic target.


Subject(s)
Autophagy/physiology , Cerebral Infarction/pathology , Cerebral Infarction/physiopathology , Ischemic Stroke/pathology , Ischemic Stroke/physiopathology , Animals , Disease Models, Animal , Humans
2.
Int J Neurosci ; 132(12): 1254-1260, 2022 Dec.
Article in English | MEDLINE | ID: mdl-33527868

ABSTRACT

PURPOSE: Spontaneous axonal plasticity and functional restoration after stroke may be limited by Nogo-A, a myelin-associated inhibitor, via activation of the Rho/Rho-associated protein kinase (ROCK) pathway. Constraint-induced movement therapy (CIMT) is a rehabilitation technique based on neuroplasticity and neural recombination. We recently reported that CIMT promoted neurogenesis after cerebral ischemia/reperfusion in part by inhibiting the Nogo-A-RhoA-ROCK pathway. Here, we examine the hypothesis that CIMT combined with the ROCK inhibitor fasudil further amplifies neurogenesis during stroke recovery. METHODS: Four groups of rats were randomized as follows: Cerebral ischemia-reperfusion (IR), Fasudil, CIMT and CIMT + Fasudil. Seven days after stroke, CIMT and/or intraperitoneal infusion of fasudil were initiated and continued for 3 weeks. The behavioral outcomes and immunohistochemical markers of neurogenesis were quantified. RESULTS: Compared with other groups, the combination of CIMT with fasudil after IR significantly improved motor and memory function recovery. In addition, BrdU, BrdU/doublecortin and BrdU/GFAP all increased significantly in the brain tissue of the combined treatment group compared to the CIMT or Fasudil group. CONCLUSION: These results suggest that the effects of CIMT on neurogenesis are amplified by fasudil during the recovery phase after stroke.


Subject(s)
Brain Ischemia , Cerebral Infarction , Reperfusion Injury , Animals , Rats , Brain Ischemia/physiopathology , Brain Ischemia/therapy , Bromodeoxyuridine , Cerebral Infarction/physiopathology , Cerebral Infarction/therapy , Neurogenesis/physiology , Nogo Proteins , Reperfusion Injury/physiopathology , Reperfusion Injury/therapy , Stroke/physiopathology , Stroke/therapy
3.
Retina ; 42(2): 340-347, 2022 02 01.
Article in English | MEDLINE | ID: mdl-34608107

ABSTRACT

PURPOSE: To determine the relationship between macular microvascular abnormalities on optical coherence tomography angiography and silent cerebral infarctions (SCIs) on cerebral magnetic resonance imaging in sickle cell disease. METHODS: Patients (age <18 years old) from our previous pediatric sickle cell disease study cohort who had prior optical coherence tomography angiography and brain magnetic resonance imaging were identified. Brain magnetic resonance imaging images were compared with macular optical coherence tomography angiography scans to identify macular vascular density differences between patients with SCI and without SCI. RESULTS: Sixty-eight eyes from 34 patients who underwent optical coherence tomography angiography were evaluated, of whom 28 eyes from 14 patients met the inclusion criteria for this study. Eight patients (57%) with SCI and 6 patients (43%) without SCI were identified. The mean age (17 years in SCI and 16.3 years in non-SCI) was comparable between groups. There was no statistically significant difference in systemic complications. Deep capillary plexus vessel density was lower in the temporal quadrant in patients with SCI (49.3% vs. 53.7%, P = 0.014). CONCLUSION: Patients with SCI were found to have lower vessel density in the deep capillary plexus compared with those without SCI. This finding suggests that deep capillary plexus vessel density may have utility as an imaging biomarker to predict the presence of SCI.


Subject(s)
Anemia, Sickle Cell/physiopathology , Cerebral Infarction/physiopathology , Cerebrovascular Circulation/physiology , Computed Tomography Angiography , Macula Lutea/blood supply , Retinal Vessels/physiology , Tomography, Optical Coherence , Adolescent , Anemia, Sickle Cell/diagnostic imaging , Biomarkers , Blood Flow Velocity , Cerebral Infarction/diagnostic imaging , Cross-Sectional Studies , Female , Humans , Macula Lutea/diagnostic imaging , Magnetic Resonance Imaging , Male , Regional Blood Flow/physiology , Retinal Vessels/diagnostic imaging , Retrospective Studies
4.
J Am Heart Assoc ; 10(24): e022880, 2021 12 21.
Article in English | MEDLINE | ID: mdl-34889115

ABSTRACT

Background We retrospectively compared early- (<6 hours) versus late- (6-24 hours) presenting patients using perfusion-weighted imaging selection and evaluated clinical/radiographic outcomes. Methods and Results Large vessel occlusion patients treated with mechanical thrombectomy from August 2017 to July 2020 within 24 hours of onset were retrieved from a single-center database. Perfusion-weighted imaging was analyzed by automated software and final infarct volume was measured semi-automatically within 14 days. The primary end point was good outcome (modified Rankin Scale 0-2 at 90 days). Secondary end points were excellent outcome (modified Rankin Scale 0-1 at 90 days), symptomatic intracranial hemorrhage, and death. Clinical characteristics/radiological values including hypoperfusion volume and infarct growth velocity (baseline volume/onset-to-image time) were compared between the groups. Of 1294 patients, 118 patients were included. The median age was 74 years, baseline National Institutes of Health Stroke Scale score was 14, and core volume was 13 mL. The late-presenting group had more female patients (67% versus 31%, respectively; P=0.001). No statistically significant differences were seen in good outcome (42% versus 53%, respectively; P=0.30), excellent outcome (26% versus 32%, respectively; P=0.51), symptomatic intracranial hemorrhage (6.5% versus 4.6%, respectively; P=0.74), and death (3.2% versus 5.7%, respectively; P=0.58) between the groups. The late-presenting group had more atherothrombotic cerebral infarction (19% versus 6%, respectively; P=0.03), smaller hypoperfusion volume (median: 77 versus 133 mL, respectively; P=0.04), and slower infarct growth velocity (median: 0.6 versus 5.1 mL/h, respectively; P=0.03). Conclusions Patients with early- and late-time windows treated with mechanical thrombectomy by automated perfusion-weighted imaging selection have similar outcomes, comparable with those in randomized trials, but different in infarct growth velocities. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT02251665.


Subject(s)
Cerebral Infarction , Stroke , Thrombectomy , Aged , Blood Flow Velocity , Cerebral Infarction/physiopathology , Female , Humans , Male , Retrospective Studies , Stroke/surgery , Thrombectomy/methods , Time Factors , Treatment Outcome
5.
Pak J Pharm Sci ; 34(5(Special)): 2065-2069, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34862875

ABSTRACT

To investigate the therapeutic effect of Danhong injection on diabetic patients with cerebral infarction and its influence on vascular endothelial function and hemodynamic level. A total of 100 diabetic patients with cerebral infarction admitted to our hospital from November 2019 to November 2020 were identified as the research subjects and randomly divided into a control group given routine treatment and a study group treated with Danhong injection, with 50 cases in each group. The efficiency of the two groups on vascular endothelial function, blood glucose level, National Institute of Health Stroke Scale (NIHSS) score, the incidence of adverse reactions, and hemodynamic indicators were compared. Most (98%) of patients in the study group displayed effective outcomes, which was significantly better than that in the control group. The study group outperformed the control study group in the vascular endothelial function, blood glucose level, NIHSS score and hemodynamic indicators (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Danhong injection obtains a promising therapeutic effect on diabetic patients with cerebral infarction, as it significantly improves the vascular endothelial function and hemodynamic level.


Subject(s)
Cerebral Infarction/drug therapy , Diabetes Mellitus/drug therapy , Drugs, Chinese Herbal/administration & dosage , Endothelium, Vascular/drug effects , Hemodynamics/drug effects , Adult , Blood Glucose/drug effects , Blood Glucose/metabolism , Case-Control Studies , Cerebral Infarction/blood , Cerebral Infarction/diagnosis , Cerebral Infarction/physiopathology , Diabetes Mellitus/blood , Diabetes Mellitus/diagnosis , Diabetes Mellitus/physiopathology , Drugs, Chinese Herbal/adverse effects , Endothelium, Vascular/physiopathology , Female , Humans , Injections, Intravenous , Male , Middle Aged , Random Allocation , Time Factors , Treatment Outcome
6.
PLoS One ; 16(11): e0255200, 2021.
Article in English | MEDLINE | ID: mdl-34752461

ABSTRACT

The photochemically-induced thrombosis (photothrombosis) method can create focal cerebral infarcts anywhere in the relatively superficial layers of the cerebrum; it is easy to implement and minimally invasive. Taking advantage of this versatility, we aimed to establish a new rat model of urinary frequency with focal cerebral infarction, which was characterized by its simplicity, nonlethal nature, and high reproducibility. The prefrontal cortex and the anterior cingulate cortex, which are involved in lower urinary tract control, were targeted for focal cerebral infarction, and urinary parameters were measured by cystometrogram. Cystometric analysis indicated that micturition intervals significantly shortened in photothrombosis-treated rats compared with those in the sham operative group on Days 1 and 7 (P < 0.01), but prolonged after 14 days, with no difference between the two groups. Immunopathological evaluation showed an accumulation of activated microglia, followed by an increase in reactive astrocytes at the peri-infarct zone after photothrombotic stroke. Throughout this study, all postphotothrombosis rats showed cerebral infarction in the prefrontal cortex and anterior cingulate cortex; there were no cases of rats with fatal cerebral infarction. This model corresponded to the clinical presentation, in that the micturition status changed after stroke. In conclusion, this novel model combining nonlethality and high reproducibility may be a suitable model of urinary frequency after focal cerebral infarction.


Subject(s)
Cerebral Infarction/physiopathology , Urinary Bladder, Overactive/physiopathology , Urinary Bladder/physiopathology , Animals , Cerebral Infarction/complications , Disease Models, Animal , Female , Rats , Rats, Wistar , Thrombosis , Urinary Bladder, Overactive/etiology
7.
Dis Markers ; 2021: 6103961, 2021.
Article in English | MEDLINE | ID: mdl-34630737

ABSTRACT

BACKGROUND: Previous studies reported that the level of serum uric acid (SUA) was an important risk factor for acute cerebral infarction (ACI). However, the prognostic value of SUA levels in hospitalized patients with ACI has not been fully elucidated. The aim of this study was to investigate whether the SUA level on admission was associated with subsequent mortality in hospitalized patients with ACI. METHODS: The clinical data of ACI patients obtained from December 2017 to December 2019 were retrospectively reviewed. χ 2 and Kaplan-Meier methods were used to compare the clinical differences and overall survival between patients with or without hyperuricemia, respectively. Univariate and multivariate analyses were used to identify independent prognoses. RESULTS: In the total population, the in-hospital mortality of the hyperuricemia group was significantly higher than that of the normal uric acid group (P = 0.006). In the abnormal renal function group, the in-hospital mortality among the hyperuricemia group was significantly higher than the normal uric acid group (P = 0.002). However, there was no statistical difference of in-hospital mortality between the two groups in the normal renal function group (P = 0.321). Univariate and multivariate analyses showed that a previous history of diabetes (P = 0.018), hyperuricemia (P = 0.001), and National Institutes of Health Stroke Scale (NIHSS) score on admission (P ≤ 0.001) were independent factors for all samples. The hyperuricemia (P = 0.003) on admission were independent factors for patients with abnormal renal function. CONCLUSIONS: In ACI patients with abnormal renal function, hyperuricemia may be associated with higher in-hospital mortality than patients with normal uric acid, and hyperuricemia may be an independent associated factor for in-hospital death in the subgroup patients.


Subject(s)
Cerebral Infarction/mortality , Hyperuricemia/mortality , Uric Acid/blood , Aged , Aged, 80 and over , Cerebral Infarction/blood , Cerebral Infarction/physiopathology , Female , Hospital Mortality , Humans , Hyperuricemia/diagnosis , Hyperuricemia/physiopathology , Inpatients , Kaplan-Meier Estimate , Kidney Function Tests , Male , Multivariate Analysis , Prognosis , Retrospective Studies , Risk Factors
8.
Neural Plast ; 2021: 7031178, 2021.
Article in English | MEDLINE | ID: mdl-34659397

ABSTRACT

Purpose. We investigated the disparate influence of lesion location on functional damage and reorganization of the sensorimotor brain network in patients with thalamic infarction and pontine infarction. Methods. Fourteen patients with unilateral infarction of the thalamus and 14 patients with unilateral infarction of the pons underwent longitudinal fMRI measurements and motor functional assessment five times during a 6-month period (<7 days, at 2 weeks, 1 month, 3 months, and 6 months after stroke onset). Twenty-five age- and sex-matched controls underwent MRI examination across five consecutive time points in 6 months. Functional images from patients with left hemisphere lesions were first flipped from the left to the right side. The voxel-wise connectivity analyses between the reference time course of each ROI (the contralateral dorsal lateral putamen (dl-putamen), pons, ventral anterior (VA), and ventral lateral (VL) nuclei of the thalamus) and the time course of each voxel in the sensorimotor area were performed for all five measurements. One-way ANOVA was used to identify between-group differences in functional connectivity (FC) at baseline stage (<7 days after stroke onset), with infarction volume included as a nuisance variable. The family-wise error (FWE) method was used to account for multiple comparison issues using SPM software. Post hoc repeated-measure ANOVA was applied to examine longitudinal FC reorganization. Results. At baseline stage, significant differences were detected between the contralateral VA and ipsilateral postcentral gyrus (cl_VA-ip_postcentral), contralateral VL and ipsilateral precentral gyrus (cl_VL-ip_precentral). Repeated measures ANOVA revealed that the FC change of cl_VA-ip_postcentral differ significantly among the three groups over time. The significant changes of FC between cl_VA and ip_postcentral at different time points in the thalamic infarction group showed that compared with 7 days after stroke onset, there was significantly increased FC of cl_VA-ip_postcentral at 1 month, 3 months, and 6 months after stroke onset. Conclusions. The different patterns of sensorimotor functional damage and reorganization in patients with pontine infarction and thalamic infarction may provide insights into the neural mechanisms underlying functional recovery after stroke.


Subject(s)
Cerebral Infarction/diagnostic imaging , Magnetic Resonance Imaging/trends , Nerve Net/diagnostic imaging , Pons/diagnostic imaging , Rest , Thalamus/diagnostic imaging , Adult , Aged , Cerebral Infarction/physiopathology , Female , Humans , Longitudinal Studies , Male , Middle Aged , Nerve Net/physiopathology , Pilot Projects , Pons/physiopathology , Sensorimotor Cortex/diagnostic imaging , Sensorimotor Cortex/physiopathology , Thalamus/physiopathology
9.
Bull Exp Biol Med ; 171(4): 489-493, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34542765

ABSTRACT

We studied the influence of combined preconditioning (compound pQ-4 and moderate hypoxia) on morphometrical parameters of neuronal populations in hippocampal fields CA1 and CA3 in rats after bilateral ligation of the common carotid artery. Preconditioning produced a neuroprotective effect, improved survival of pyramidal neurons in the early and delayed periods of modeled ischemia, prevented the formation of necrotic and apoptotic neurons and hyperactivation of microglia, and protected endotheliocytes. The positive influence of preconditioning factors on the morphometric parameters of the brain under ischemic conditions agrees with the results of behavioral tests (open field and elevated plus maze) that demonstrated increased locomotor activity and exploratory behavior of animals.


Subject(s)
Brain Ischemia/therapy , Central Nervous System/physiopathology , Cerebral Infarction/therapy , Ischemic Preconditioning , Animals , Behavior, Animal/physiology , Brain Ischemia/pathology , Brain Ischemia/physiopathology , Brain Ischemia/psychology , Central Nervous System/pathology , Cerebral Infarction/pathology , Cerebral Infarction/physiopathology , Cerebral Infarction/psychology , Conditioning, Psychological/physiology , Exploratory Behavior/physiology , Female , Ischemic Preconditioning/methods , Male , Neuroprotective Agents/therapeutic use , Rats , Rats, Wistar
10.
J Stroke Cerebrovasc Dis ; 30(9): 105997, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34303089

ABSTRACT

OBJECTIVES: To identify the underlying genetic defect for a consanguineous family with an unusually high number of members affected by cerebral small vessel disease. MATERIALS AND METHODS: A total of 6 individuals, of whom 3 are severely affected, from the family were clinically and radiologically evaluated. SNP genotyping was performed in multiple members to demonstrate genome-wide runs-of-homozygosity. Coding variants in the most likely candidate gene, HTRA1 were explored by Sanger sequencing. Published HTRA1-related phenotypes were extensively reviewed to explore the effect of number of affected alleles on phenotypic expression. RESULTS: Genome-wide homozygosity mapping identified a 3.2 Mbp stretch on chromosome 10q26.3 where HTRA1 gene is located. HTRA1 sequencing revealed an evolutionarily conserved novel homozygous c.824C>T (p.Pro275Leu) mutation, affecting the serine protease domain of HtrA1. Early-onset of cognitive and motor deterioration in homozygotes are in consensus with CARASIL. However, there was a clear phenotypic variability between homozygotes which includes alopecia, a suggested hallmark of CARASIL. All heterozygotes, presenting as CADASIL type 2, had spinal disk degeneration and several neuroimaging findings, including leukoencephalopathy and microhemorrhage despite a lack of severe clinical presentation. CONCLUSION: Here, we clearly demonstrate that CARASIL and CADASIL type 2 are two clinical consequences of the same disorder with different severities thorough the evaluation of the largest collection of homozygotes and heterozygotes segregating in a family. Considering the semi-dominant inheritance of HTRA1-related phenotypes, genetic testing and clinical follow-up must be offered for all members of a family with HTRA1 mutations regardless of symptoms.


Subject(s)
Alopecia/genetics , CADASIL/genetics , Cerebral Infarction/genetics , High-Temperature Requirement A Serine Peptidase 1/genetics , Leukoencephalopathies/genetics , Mutation , Spinal Diseases/genetics , Adult , Age of Onset , Alopecia/diagnosis , Alopecia/physiopathology , CADASIL/diagnosis , CADASIL/physiopathology , Cerebral Infarction/diagnosis , Cerebral Infarction/physiopathology , Consanguinity , DNA Mutational Analysis , Female , Genetic Predisposition to Disease , Heredity , Heterozygote , Homozygote , Humans , Leukoencephalopathies/diagnosis , Leukoencephalopathies/physiopathology , Male , Middle Aged , Pedigree , Phenotype , Severity of Illness Index , Spinal Diseases/diagnosis , Spinal Diseases/physiopathology
11.
J Clin Neurosci ; 90: 363-369, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34275577

ABSTRACT

OBJECTIVE: To investigate the effects of paired associated stimulation (PAS) with different stimulation position on motor cortex excitability and upper limb motor function in patients with cerebral infarction. METHOD: A total of 120 volunteers with cerebral infarction were randomly divided into four groups. Based on conventional rehabilitation treatment, the PAS stimulation group was given the corresponding position of PAS treatment once a day for 28 consecutive days. The MEP amplitude and RMT of both hemispheres were assessed before and after treatment, and a simple upper limb Function Examination Scale (STEF) score, simplified upper limb Fugl-Meyer score (FMA), and improved Barthel Index (MBI) were used to assess upper limb motor function in the four groups. RESULTS: Following PAS, the MEP amplitude decreased, and the RMT of abductor pollicis brevis (APB) increased on the contralesional side, while the MEP amplitude increased and the RMT of APB decreased on the ipsilesional side. After 28 consecutive days the scores of STEF, FMA, and MBI in the bilateral stimulation group were significantly better than those in the ipsilesional stimulation group and the contralesional stimulation group, but there was no significant difference in the scores of STEF, FMA, and MBI between the ipsilesional stimulation group and the contralesional stimulation group. CONCLUSION: The excitability of the motor cortex can be changed when the contralesional side or the ipsilesional side was given the corresponding PAS stimulation, while the bilateral PAS stimulation can more easily cause a change of excitability of the motor cortex, resulting in better recovery of the upper limb function.


Subject(s)
Cerebral Infarction/physiopathology , Cerebral Infarction/rehabilitation , Electric Stimulation Therapy , Motor Cortex/physiopathology , Upper Extremity/physiopathology , Adult , Evoked Potentials, Motor , Female , Functional Laterality , Humans , Male , Middle Aged , Muscle, Skeletal/innervation , Muscle, Skeletal/physiology , Stroke Rehabilitation/methods , Transcranial Magnetic Stimulation
12.
J Integr Neurosci ; 20(2): 341-347, 2021 Jun 30.
Article in English | MEDLINE | ID: mdl-34258932

ABSTRACT

A growing number of studies have demonstrated the role of quantitative electroencephalography in assessing brain function in neuro-intensive care units. Still, few studies have examined patients with large hemisphere infarction. Thirty patients with large hemisphere infarction were included in this preliminary study, and the patients were divided into the death group (twelve patients) and survival group (eighteen patients). Electroencephalography monitored the patients, and a computerized tomography inspection was performed. The quantitative electroencephalography of the alpha-beta/delta-theta ratio change index was calculated and used to predict the prognosis of early large hemisphere infarction patients. The relationship between three months modified Rankin Scale, and alpha-beta/delta-theta ratio change index was analyzed. The death group had negative changes for alpha-beta/delta-theta ratio change index (-0.0140 ± 0.0193), while there was an opposite trend in the survival group, the median is 0.004 (-0.0067, 0.0137). The death group's brain function decreased more severely and rapidly than the survival group (P = 0.004). The highest diagnostic value (AUC value 0.815, P < 0.001) was observed when the alpha-beta/delta-theta ratio change index dropped and exceeded -0.008. The area under the GCS curve was 0.674, but its predictive ability was low (P = 0.094). The correlation analysis result showed that the 3-month modified Rankin Scale was negatively correlated with the alpha-beta/delta-theta ratio change index (r = -0.489, P = 0.006). The alpha-beta/delta-theta ratio change index is considered an indicator for predicting the prognosis of large hemisphere infarction. Therefore, the alpha-beta/delta-theta ratio change index may be a reliable quantitative EEG parameter that predicts the early prognosis of patients with acute large hemispheric infarction.


Subject(s)
Brain Waves/physiology , Cerebral Infarction/diagnosis , Cerebral Infarction/physiopathology , Electroencephalography/standards , Aged , Electroencephalography/methods , Female , Humans , Male , Middle Aged , Prognosis , Severity of Illness Index
13.
J Stroke Cerebrovasc Dis ; 30(9): 105914, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34217065

ABSTRACT

BACKGROUND: The risk of early recurrent cerebral infarction (RCI) is high in patients with symptomatic intracranial atherosclerotic disease (IAD). We sought to determine the relationship between risk factor control and early RCI risk among patients with symptomatic IAD. METHODS: We analyzed participants with symptomatic IAD in the multi-center prospective observational MYRIAD study. Risk factor control was assessed at 6-8-week follow-up. Optimal risk factor control was defined by target systolic blood pressure, being non-smoker, target physical activity, and antiplatelet and antilipidemic therapy compliance. Age-adjusted associations were calculated between risk factor control and RCI determined by MRI-evident new infarcts in the territory of the stenotic vessel at 6-8 weeks from the index event. RESULTS: Among 82 participants with clinical and brain MRI information available 6-8 weeks after the index event (mean age 63.5 ±12.5 years, 62.2% men), RCI occurred in 21 (25.6%) cases. At 6-8-week follow-up, 37.8% had target systolic blood pressure, 92.7% were non-smokers, 51.2% had target physical activity, and 98.8% and 86.6% were compliant with antiplatelet and antilipidemic therapy, respectively. Optimal risk factor control increased from 4.9% at baseline to 19.5% at 6-8-week follow-up (p=0.01). None of the participants with optimal risk factor control at follow-up had RCI (0% vs. 31.8%, p<0.01). CONCLUSIONS: Only one-fifth of MYRIAD participants had optimal risk factor control during early follow-up. Approximately half and two-thirds had physical inactivity and uncontrolled systolic blood pressure, respectively. These risk factors may represent important therapeutic targets to prevent early RCI in patients with symptomatic IAD.


Subject(s)
Antihypertensive Agents/therapeutic use , Cerebral Infarction/prevention & control , Hypolipidemic Agents/therapeutic use , Intracranial Arteriosclerosis/therapy , Platelet Aggregation Inhibitors/therapeutic use , Risk Reduction Behavior , Secondary Prevention , Aged , Blood Pressure/drug effects , Cerebral Infarction/diagnostic imaging , Cerebral Infarction/etiology , Cerebral Infarction/physiopathology , Exercise , Female , Humans , Intracranial Arteriosclerosis/complications , Intracranial Arteriosclerosis/diagnostic imaging , Intracranial Arteriosclerosis/physiopathology , Male , Medication Adherence , Middle Aged , Prospective Studies , Recurrence , Risk Assessment , Risk Factors , Sedentary Behavior , Smoking Cessation , Time Factors , Treatment Outcome , United States
14.
Brain Res ; 1767: 147542, 2021 09 15.
Article in English | MEDLINE | ID: mdl-34077764

ABSTRACT

Cerebral infarction causes motor, sensory, and cognitive impairments. Although rehabilitation enhances recovery of activities of daily living after cerebral infarction, its mechanism remains elusive due to the lack of reproducibility and low survival rate of brain ischemic model animals. Here, to investigate the relationship between rehabilitative intervention, motor function, and pathophysiological remodeling of the tissue in the ipsilateral hemisphere after cerebral infarction, we took advantage of a highly reproducible model of cerebral infarction using C.B-17/Icr-+/+Jcl mice. In this model, we confirmed that voluntary running exercise improved functional recovery after ischemia. Exercise did not alter the volume of infarction or survived cortex, or the number of NeuN-labeled cells in the peri-infarct cortex. In mice who did not exercise, the number of basal dendritic spines of layer 5 pyramidal cells decreased in the peri-infarct motor cortex, whereas in mice who exercised it remained at the normal level. The voluntary exercise intervention maintained basal dendritic spine density within the peri-infarct area, which may reflect an adaptive remodeling of the surviving neural circuitry that might contribute to promoting the recovery of activities of daily living.


Subject(s)
Brain Ischemia/therapy , Dendritic Spines/physiology , Recovery of Function/physiology , Animals , Cerebral Infarction/physiopathology , Dendritic Spines/metabolism , Disease Models, Animal , Male , Mice , Mice, Inbred CBA , Motor Cortex/physiopathology , Neuronal Plasticity/physiology , Physical Conditioning, Animal/methods , Pyramidal Cells , Reproducibility of Results , Running
15.
Sci Rep ; 11(1): 13372, 2021 06 28.
Article in English | MEDLINE | ID: mdl-34183726

ABSTRACT

The relationship between exercise and stroke recurrence is controversial. This study was designed to test whether an association exists between exercise and ischemic stroke recurrence in first-ever ischemic stroke survivors. Data were collected from January 2010 to June 2016. Baseline information was obtained during face-to-face interviews, and follow-up phone interviews were conducted every 3 months. Exercise type, frequency, intensity, and duration were recorded. Discrete-time survival analysis was used to determine the relationship between exercise and stroke recurrence. 760 first-ever ischemic stroke survivors who were able to exercise were enrolled. After adjusting for covariates, patients who exercised 3.5-7 h per week and more than 7 h per week had a lower relapse risk than patients who did not exercise (3.5-7: OR 0.415; > 7: OR 0.356). Moreover, if the fluctuation of exercise duration was over 4 h, the patients had a higher risk of stroke recurrence than those with variability of less than 2 h (OR 2.153, P = 0.013). Stroke survivors who engage in long-term regular mild exercise (more than 5 sessions per week and lasting on average 40 min per session) have a lower recurrence rate. Irregular exercise increases the risk of stroke recurrence.


Subject(s)
Brain Ischemia/physiopathology , Exercise/physiology , Ischemic Stroke/physiopathology , Adolescent , Adult , Aged , Aged, 80 and over , Cerebral Infarction/physiopathology , Female , Humans , Male , Middle Aged , Recurrence , Risk Factors , Survival Analysis , Survivors , Young Adult
16.
J Cereb Blood Flow Metab ; 41(11): 2820-2830, 2021 11.
Article in English | MEDLINE | ID: mdl-34112003

ABSTRACT

Aneurysmal subarachnoid hemorrhage (aSAH) patients develop delayed cerebral ischemia and delayed deficits (DCI) within 2 weeks of aneurysm rupture at a rate of approximately 30%. DCI is a major contributor to morbidity and mortality after SAH. The cause of DCI is multi-factorial with contributions from microthrombi, blood vessel constriction, inflammation, and cortical spreading depolarizations. Platelets play central roles in hemostasis, inflammation, and vascular function. Within this review, we examine the potential roles of platelets in microthrombi formation, large artery vasospasm, microvessel constriction, inflammation, and cortical spreading depolarization. Evidence from experimental and clinical studies is provided to support the role(s) of platelets in each pathophysiology which contributes to DCI. The review concludes with a suggestion for future therapeutic targets to prevent DCI after aSAH.


Subject(s)
Blood Platelets/physiology , Cerebral Infarction/physiopathology , Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors , Subarachnoid Hemorrhage/physiopathology , Aneurysm, Ruptured/complications , Aneurysm, Ruptured/epidemiology , Animals , Cerebral Infarction/complications , Cerebral Infarction/prevention & control , Constriction , Cortical Spreading Depression/physiology , Endothelium-Dependent Relaxing Factors/pharmacology , Epoprostenol/pharmacology , Humans , Inflammation/physiopathology , Intracranial Thrombosis/physiopathology , Microvessels/physiopathology , Models, Animal , Nervous System Diseases/epidemiology , Nitric Oxide/pharmacology , Platelet Aggregation Inhibitors/pharmacology , Subarachnoid Hemorrhage/epidemiology , Subarachnoid Hemorrhage/mortality , Time Factors , Vasospasm, Intracranial/physiopathology
17.
Sci Rep ; 11(1): 12496, 2021 06 14.
Article in English | MEDLINE | ID: mdl-34127706

ABSTRACT

Transcranial electrical stimulated motor-evoked potentials (tcMEPs) are widely used to evaluate motor function in humans, and even in animal studies, tcMEPs are used to evaluate neurological dysfunction. However, there is a dearth of reports on extended tcMEP recordings in both animal models and humans. Therefore, this study examined a new technique for stably recording tcMEPs over several weeks in six healthy female Sprague-Dawley rats. We thinned the skull bone using the skull base and spinal surgery technique to reduce electrical resistance for electrical stimulation. tcMEPs were recorded on days 1, 7, 14, 21, and 28 after surgery. The onset latency and amplitude of tcMEPs from the hindlimbs were recorded and evaluated, and histological analysis was performed. Stable amplitude and onset latency could be recorded over several weeks, and histological analysis indicated no complications attributable to the procedure. Thus, our novel technique allows for less invasive, safer, easier, and more stable extended tcMEP recordings than previously reported techniques. The presently reported technique may be applied to the study of various nerve injury models in rats: specifically, to evaluate the degree of nerve dysfunction and recovery in spinal cord injury, cerebral infarction, and brain contusion models.


Subject(s)
Evoked Potentials, Motor/physiology , Skull/surgery , Transcranial Direct Current Stimulation/methods , Animals , Brain Contusion/diagnosis , Brain Contusion/physiopathology , Brain Contusion/surgery , Cerebral Infarction/diagnosis , Cerebral Infarction/physiopathology , Cerebral Infarction/surgery , Disease Models, Animal , Electromyography , Female , Hindlimb/physiology , Humans , Monitoring, Intraoperative/methods , Neurosurgical Procedures/methods , Rats , Rats, Sprague-Dawley , Spinal Cord Injuries/diagnosis , Spinal Cord Injuries/physiopathology , Spinal Cord Injuries/surgery
18.
Medicine (Baltimore) ; 100(23): e26280, 2021 Jun 11.
Article in English | MEDLINE | ID: mdl-34115027

ABSTRACT

ABSTRACT: Despite lacking aphasia seen with left hemisphere (LH) infarcts involving the middle cerebral artery territory, right hemisphere (RH) strokes can result in significant difficulties in affective prosody. These impairments may be more difficult to identify but lead to significant communication problems.We determine if evaluation of singing can accurately identify stroke patients with cortical RH infarcts at risk for prosodic impairment who may benefit from rehabilitation.A prospective cohort of 36 patients evaluated with acute ischemic stroke was recruited. Participants underwent an experimental battery evaluating their singing, prosody comprehension, and prosody production. Singing samples were rated by 2 independent reviewers as subjectively "normal" or "abnormal," and analyzed for properties of the fundamental frequency. Relationships between infarct location, singing, and prosody performance were evaluated using t tests and chi-squared analysis.Eighty percent of participants with LH cortical strokes were unable to successfully complete any of the tasks due to severe aphasia. For the remainder, singing ratings corresponded to stroke location for 68% of patients. RH cortical strokes demonstrated a lower mean fundamental frequency while singing than those with subcortical infarcts (176.8 vs 130.4, P = 0.02). They also made more errors on tasks of prosody comprehension (28.6 vs 16.0, P < 0.001) and production (40.4 vs 18.4, P < 0.001).Patients with RH cortical infarcts are more likely to exhibit impaired prosody comprehension and production and demonstrate the poor variation of tone when singing compared to patients with subcortical infarcts. A simple singing screen is able to successfully identify patients with cortical lesions and potential prosodic deficits.


Subject(s)
Cerebral Cortex , Cerebral Infarction , Singing/physiology , Speech Intelligibility/physiology , Speech Production Measurement/methods , Affective Symptoms/diagnosis , Affective Symptoms/etiology , Aged , Cerebral Cortex/blood supply , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/pathology , Cerebral Infarction/diagnosis , Cerebral Infarction/physiopathology , Cerebral Infarction/psychology , Diagnosis, Differential , Diffusion Magnetic Resonance Imaging/methods , Female , Humans , Infarction, Middle Cerebral Artery/diagnostic imaging , Ischemic Stroke/diagnosis , Male
19.
Biomed Res Int ; 2021: 6626604, 2021.
Article in English | MEDLINE | ID: mdl-33997031

ABSTRACT

OBJECTIVE: Currently, the standard treatment modality for patients with acute ischemic stroke (AIS) presenting with isolated M2 occlusions is not specific. We therefore assessed the difference in treatment outcomes for patients with isolated M2 occlusions. METHODS: We retrospectively analyzed consecutive patients with AIS presenting with isolated M2 occlusions from October 1, 2018, to June 30, 2020. Patients were divided into 3 groups based on the treatments they received: no reperfusion therapy (NRT), intravenous thrombolysis treatment (IVT), and endovascular intervention (EVT), which comprised IVT in conjunction with EVT or EVT alone. The primary outcomes were improvements in modified Rankin Scale (mRS) scores at 90 days and National Institutes of Health Stroke Scale (NIHSS) scores at 24 hours after treatment compared with the baseline. The secondary efficacy outcome comprised a good outcome rate defined as a 90 - day mRS score ≤ 2, final infarct volume (FIV), 90-day mortality rate, and successful recanalization rate, which was defined as a modified thrombolysis in cerebral infarction score ≥ 2b. Safety outcomes included symptomatic intracerebral hemorrhage and procedure-related complications. RESULTS: Seventy patients were enrolled and divided into 3 groups: the NRT group (n = 25), IVT group (n = 27), and EVT group (n = 18). Twenty-four-hour posttreatment NIHSS scores were substantially decreased by EVT compared with NRT (adjusted ß -4.01, 95% confidence interval [CI] -6.60 to -1.43; P = 0.003) or IVT (adjusted ß, -3.61 [95% CI, -6.45 to -0.77]; P = 0.013). Compared with the outcomes observed after NRT, patients who received EVT were more likely to achieve lower 90-day mRS scores (adjusted ß, -1.42 [95% CI, -2.66 to -0.63]; P = 0.007), higher good outcome rates (adjusted odds ratio, 8.73 [95% CI, 1.43-53.24]; P = 0.019), and smaller FIVs (adjusted ß, -29.66 [95% CI, -59.73 to 0.42]; P = 0.048). The recanalization rate of EVT was high (88.89%), and procedure-related complications were rare (5.56%). CONCLUSIONS: For acute, isolated M2 occlusions, EVT could dramatically and rapidly improve neurological deficits with high safety and effectiveness. These changes were observed at 24 hours after treatment and were maintained over the long term.


Subject(s)
Cerebral Infarction , Endovascular Procedures , Ischemic Stroke , Thrombolytic Therapy , Aged , Aged, 80 and over , Cerebral Hemorrhage , Cerebral Infarction/mortality , Cerebral Infarction/physiopathology , Cerebral Infarction/therapy , Female , Humans , Ischemic Stroke/mortality , Ischemic Stroke/physiopathology , Ischemic Stroke/therapy , Male , Reperfusion , Retrospective Studies , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...